Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Puel

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
The Journal of Experimental Medicine|January 4, 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenPaul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine|July 9, 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosisDiana Olguín Calderón, Laura E Kilpatrick, Clément Conil, et al.
Frontiers in Immunology|May 9, 2022
Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021)Brahim Belaid, Lydia Lamara Mahammed, Ouardia Drali, et al.
The Journal of Experimental Medicine|October 1, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseasesJérémie Rosain, Tom Le Voyer, Xian Liu, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 19, 2024
Germline mutations in a G protein identify signaling cross-talk in T cellsHyoungjun Ham, Huie Jing, Ian T Lamborn, et al.
Science Immunology|August 20, 2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19Takaki Asano, Bertrand Boisson, Fanny Onodi, et al.
The Journal of Experimental Medicine|March 8, 2023
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic diseaseMehul Sharma, Daniel Leung, Mana Momenilandi, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
The Journal of Experimental Medicine|January 4, 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenPaul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine|July 9, 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosisDiana Olguín Calderón, Laura E Kilpatrick, Clément Conil, et al.
Frontiers in Immunology|May 9, 2022
Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021)Brahim Belaid, Lydia Lamara Mahammed, Ouardia Drali, et al.
The Journal of Experimental Medicine|October 1, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseasesJérémie Rosain, Tom Le Voyer, Xian Liu, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 19, 2024
Germline mutations in a G protein identify signaling cross-talk in T cellsHyoungjun Ham, Huie Jing, Ian T Lamborn, et al.
Science Immunology|August 20, 2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19Takaki Asano, Bertrand Boisson, Fanny Onodi, et al.
The Journal of Experimental Medicine|March 8, 2023
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic diseaseMehul Sharma, Daniel Leung, Mana Momenilandi, et al.
Pageof 30